Veterinary Medicines

Rispoval IBR-Marker InactivatumSuspension for injection for cattle

Authorised
  • Bovine herpesvirus 1, strain Difivac gE gene-deleted, Inactivated
Download as PDF

Product identification

Medicine name:
Rispoval IBR-Marker InactivatumSuspension for injection for cattle
Rispoval IBR-Marker Inactivatum, injekcinė suspensija galvijams
Active substance:
  • Bovine herpesvirus 1, strain Difivac gE gene-deleted, Inactivated
Target species:
  • Cattle
  • Cattle (for meat production)
  • Cattle (calf)
  • Cattle (heifer)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Bovine herpesvirus 1, strain Difivac gE gene-deleted, Inactivated
    0.01
    titre
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cattle (for meat production)
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Cattle (heifer)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • (ID3) 100 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 100 millilitre(s)
  • (ID2) 20 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 20 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/08/1794/001-002
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0021/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • France
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 10/02/2022
Download

Combined File of all Documents

English (PDF)
Published on: 28/06/2024
Download

RV1794.pdf

Lithuanian (PDF)
Published on: 26/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."